Episodit
-
In this episode, we explore strategies for discontinuing benzodiazepines in hospitalized elderly patients. We discuss a recent Israeli study that tested two interventions during inpatient stays. Can a simple hospital-based intervention lead to successful long-term medication changes?
Faculty: Paul Zarkowski, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 61 Stopping Benzodiazepines and Z-Drugs in Hospitalized Elderly Patients
Host: Richard Seeber, M.D. -
In this episode, we explore the critical role of therapeutic alliance in psychopharmacology. We discuss how factors like empathy, communication, and shared decision-making can significantly impact treatment outcomes. Did you know that a doctor's warm voice can increase appointment adherence by 162%?
Faculty: David Mintz, M.D.
Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills Pharmacotherapy Alliance, Treatment Preferences, and Communication
Host: Richard Seeber, M.D. -
Puuttuva jakso?
-
In this episode, we explore the cardiac and metabolic safety profile of antipsychotics in youth, based on a World Health Organization Safety Database analysis. We discuss age-dependent risks, specific medication concerns, and the importance of monitoring. How can clinicians balance the benefits of antipsychotics with potential cardiometabolic risks in young patients?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 20 Cardiac and Metabolic Safety Profile of Antipsychotics in Youth
Host: Richard Seeber, M.D. -
In this episode, we explore the unexpected consequences of promoting a purely biological view of mental illness. How does framing mental health conditions as solely biological affect stigma, patient outcomes, and physician empathy? We delve into the complex interplay between biological and psychosocial factors in mental health treatment.
Faculty: David Mintz, M.D.
Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills The Biological Theory of Illness and Stigma
Host: Richard Seeber, M.D. -
In this episode, we explore the bidirectional relationship between psychiatric disorders and cardiovascular disease, discussing a groundbreaking study involving over 900,000 subjects. We ask: Can a mental health diagnosis increase your risk of heart disease?
Faculty: Scott Beach, M.D.
Learn more about our membership her Earn 0.5 CMEs: Quick Take Vol. 60 Psychiatric Disorders and Subsequent Risk of Cardiovascular Disease
Host: Richard Seeber, M.D. -
In this episode, we explore the science behind the art of psychopharmacotherapy with Dr. David Mintz. We delve into how psychosocial factors, including the prescriber's approach, can significantly impact medication outcomes. Did you know that some psychiatrists achieve better results with placebos than others do with active medications?
Faculty: David Mintz, M.D.
Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills The Science of the Art of Psychopharmacotherapy
Host: Richard Seeber, M.D. -
In this episode, we explore the long-term effects of methylphenidate on sleep in children and adolescents with ADHD. Can stimulant medication actually improve sleep in ADHD patients? We dive into surprising research findings that challenge common assumptions about ADHD treatment and sleep disturbances.
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 20 Long-Term Effects of Methylphenidate on Sleep in Children and Adolescents With ADHD
Host: Richard Seeber, M.D. -
In this episode, we explore the strategic use of natural medications in psychiatry, focusing on combination therapies for various mental health conditions. Dr. David Mischoulon discusses potential synergies between natural remedies and conventional drugs, as well as all-natural combinations. But how do we balance efficacy with safety when using these less-studied treatments?
Faculty: David Mischoulon, M.D.
Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies Potential Combinations of Natural Medication for Psychiatric Disorders
Host: Richard Seeber, M.D. -
In this episode, we explore the use of memantine in treating trichotillomania and skin picking disorder. Could this common Alzheimer's medication be the breakthrough we've been waiting for in managing body-focused repetitive behaviors? Dr. Bob Hudak discusses a promising study that offers new hope for patients struggling with these often-overlooked conditions.
Faculty: Robert Hudak, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 60 Efficacy of Memantine in Treating Trichotillomania and Skin-Picking Disorder
Host: Richard Seeber, M.D. -
In this episode, we explore Ashwagandha, a versatile natural remedy in psychiatry. We discuss its potential applications in treating anxiety, depression, OCD, and other mental health disorders. Could this ancient herb be the key to managing treatment-resistant patients?
Faculty: David Mischoulon, M.D.
Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies Ashwagandha (ASW): Potential Indications and Administration in Psychiatric Disorders
Host: Richard Seeber, M.D. -
In this episode, we explore the controversial use of electroconvulsive therapy (ECT) in adolescents with severe depression and suicidality. We discuss a study examining ECT's effectiveness, factors influencing outcomes, and its potential as a treatment option. Is ECT a viable last resort for treatment-resistant depression in teens?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 19 Electroconvulsive Therapy for Adolescents With Severe Depression and Suicidality
Host: Richard Seeber, M.D. -
In this episode, we explore the potential uses of Cannabidiol (CBD) in psychiatric practice. We discuss its mechanisms, evidence for various disorders, and guidelines for safe use. Is CBD the next breakthrough in mental health treatment, or just another passing trend?
Faculty: David Mischoulon, M.D.
Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies Cannabidiol: Evidence for Psychiatric Disorders and Recommendations for Using It
Host: Richard Seeber, M.D. -
In this episode, we explore the use of medical cannabis in treating Parkinson's disease. We discuss a retrospective study that reveals promising results for both motor and non-motor symptoms. Could medical cannabis be the versatile solution we've been seeking for Parkinson's treatment?
Faculty: Gregory Pontone, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 59 Medical Cannabis in the Treatment of Parkinson’s Disease
Host: Richard Seeber, M.D.
-
In this episode, we explore the potential of N-acetylcysteine (NAC) in treating mood disorders. We discuss its mechanism of action, clinical evidence for its use in depression and bipolar disorder, and its possible benefits for both adults and children. Could this natural compound revolutionize our approach to mood stabilization?
Faculty: David Mischoulon, M.D.
Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies Exploring the Evidence of N-Acetyl-Cysteine (NAC) for Mood Disorders
Host: Richard Seeber, M.D. -
In this episode, we explore the potential use of probiotics in treating ADHD symptoms in children and adolescents. Could the gut microbiome hold the key to managing this complex neurodevelopmental disorder? We discuss a recent meta-analysis and its implications for future research and clinical practice.
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 19 Efficacy of Probiotics in Treating ADHD Symptoms
Host: Richard Seeber, M.D. -
In this episode, we explore the challenges and best practices for managing bipolar disorder during pregnancy. We discuss key medications, their risks and benefits, and the importance of individualized treatment plans. How do we balance maternal mental health with fetal safety when treating bipolar disorder in pregnant women?
Faculty: Vivien Burt, M.D.
Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Guiding Principles for Treating Bipolar Disorder During Pregnancy
Host: Richard Seeber, M.D. -
In this episode, we explore a recent study challenging the safety concerns surrounding haloperidol use in older patients post-surgery. We discuss its implications for managing delirium and compare it to other antipsychotics. Could haloperidol be the unsung hero in our psychopharmacological arsenal?
Faculty: Scott Beach, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 59 Comparative Safety of Oral Antipsychotics for Adverse Events in Adults After Surgery
Host: Richard Seeber, M.D. -
In this episode, we explore the use of atypical antipsychotics during pregnancy for women with bipolar disorder. We discuss recent research findings, potential risks, and the delicate balance between managing maternal mental health and fetal safety. How do clinicians approach this challenging clinical decision?
Faculty: Vivien Burt, M.D.
Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Risks of Using Antipsychotics During Pregnancy
Host: Richard Seeber, M.D. -
In this episode, we explore the use of risperidone in treating anorexia nervosa in children and adolescents. We discuss a groundbreaking study examining its efficacy and tolerability. Can atypical antipsychotics like risperidone offer hope for young anorexia patients, or are we still searching for effective pharmacological treatments?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CME: CAP Smart Takes Vol. 18 Efficacy of Risperidone as Treatment for Anorexia Nervosa
Host: Richard Seeber, M.D. -
In this episode, we explore the complexities of managing lithium during pregnancy for women with bipolar disorder. How do lithium levels change throughout pregnancy, and what monitoring is necessary? We discuss dosing strategies, fetal monitoring, and postpartum considerations to ensure the best outcomes for both mother and baby.
Faculty: Vivien Burt, M.D.
Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Bipolar Disorder During Pregnancy: Management of Lithium
Host: Richard Seeber, M.D. - Näytä enemmän
